glp 1 slow responder Responders Beware! Don't Quit, Watch This! | EP. 03 Little Progress Is Still Progress:

In the SUSTAIN-6 trial, the plot thickens as Ozempics weight loss prowess is revealed

Food intake and lifestyle choices are undeniably important, but there are four other factors to contend with including genetics, hormones, environment and aging

For individuals managing weight or metabolic health while breastfeeding, this decision requires balancing treatment goals with infant safety

In the latter safety study, in line with most drug safety studies, in the healthy control group women comprised only 35% of the subjects, tilting potential conclusion to the male response, if different from that in females

The incretin mimetics prioritised in the NICE guideline are liraglutide, dulaglutide, injectable and oral semaglutide, and tirzepatide

Youve probably heard about GLP-1 injections like Ozempic or Mounjaro, theyre often called the weight loss shots. Originally made for people with diabetes, these medicines are now being used by many who just want to lose weight